Lercanidipine - CAS 100427-26-7
Catalog number:
100427-26-7
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C36H41N3O6
Molecular Weight:
611.73
COA:
Inquire
Targets:
Calcium Channel
Description:
Lercanidipine hydrochloride, a dihydropyridine compound, is a third generation calcium channel antagonist which shows longer duration of action of the past two generations' in the treatment of mild-to-moderate hypertension.
Publictions citing BOC Sciences Products
  • >> More
Purity:
95%
Appearance:
White to light yellow solid
Synonyms:
Lercanidipine;100427-26-7;Lercanidipine[INN];masnidipine;Lercanil(TN);Lercanidipine(INN)
Solubility:
10 mM in DMSO
Storage:
-20 ºC Freeze
MSDS:
Inquire
Application:
Lercanidipine hydrochloride is a third generation calcium channel antagonist which shows longer duration of action of the past two generations' in the treatment of mild-to-moderate hypertension.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Grams-Kilos
Boiling Point:
712.5ºC at 760 mmHg
Melting Point:
118-120ºC
Density:
1.177 g/cm3
InChIKey:
ZDXUKAKRHYTAKV-UHFFFAOYSA-N
InChI:
InChI=1S/C36H41N3O6/c1-24-31(34(40)44-6)33(28-18-13-19-29(22-28)39(42)43)32(25(2)37-24)35(41)45-36(3,4)23-38(5)21-20-30(26-14-9-7-10-15-26)27-16-11-8-12-17-27/h7-19,22,30,33,37H,20-21,23H2,1-6H3
Canonical SMILES:
CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC
1.Development and validation of reversed phase high-performance liquid chromatography method for estimation of lercanidipine HCl in pure form and from nanosuspension formulation.
Chonkar AD1, Managuli RS1, Rao JV2, Udupa N3. J Basic Clin Pharm. 2015 Dec;7(1):17-22. doi: 10.4103/0976-0105.170586.
AIM: Quantitative estimation of lercanidipine HCl in bulk material as well as from nanosuspension formulations via a developed reverse phase HPLC method.
2.Adverse event potentially due to an interaction between ibrutinib and verapamil: a case report.
Lambert Kuhn E1, Levêque D1, Lioure B2, Gourieux B1, Bilbault P3. J Clin Pharm Ther. 2016 Feb;41(1):104-5. doi: 10.1111/jcpt.12355.
WHAT IS KNOWN AND OBJECTIVE: Ibrutinib is a recently approved oral anticancer agent with pharmacokinetics that is very sensitive to metabolic inhibition. We report a serious side effect of ibrutinib potentially attributable to interaction with the moderate CYP3A4 inhibitor verapamil.
3.Development of Fast Dissolving Oral Films Containing Lercanidipine HCl Nanoparticles in Semicrystalline Polymeric Matrix for Enhanced Dissolution and Ex Vivo Permeation.
Chonkar AD1, Venkat Rao J2, Managuli RS1, Mutalik S1, Dengale S3, Jain P2, Udupa N4. Eur J Pharm Biopharm. 2016 Apr 5. pii: S0939-6411(16)30125-4. doi: 10.1016/j.ejpb.2016.04.001. [Epub ahead of print]
Lercanidipine is a vasoselective dihydropyridine calcium antagonist, mainly used for the treatment of hypertension and angina pectoris. However, it suffers from food dependent absorption, poor solubility, low permeability and considerable first pass metabolism, resulting in highly variable and low bioavailability of 10%. Nanoparticles of lercanidipine were incorporated in fast dissolving oral films (FDO) via preparation of nanosuspension by evaporative antisolvent precipitation method. Prepared nanosuspensions were incorporated in FDO without lyophilizing or spray drying. Two nanosuspensions containing PEG 400 and TPGS 1000 as stabilizers, selected further for incorporation in FDO. Physicochemical and mechanical properties of the optimised films were observed to be within acceptance criteria. SEM images as well as FTIR chemical images of oral films show uniform distribution of nano-particles in polymeric matrix. The DSC and XRD results proved the poorly crystalline nature of lercanidipine.
4.Combined mixture-process variable approach: a suitable statistical tool for nanovesicular systems optimization.
Habib BA1, AbouGhaly MH1. Expert Opin Drug Deliv. 2016 Apr 4:1-12. [Epub ahead of print]
OBJECTIVES: This study aims to illustrate the applicability of combined mixture-process variable (MPV) design and modeling for optimization of nanovesicular systems.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Calcium Channel Products


Flindokalner
(CAS: 187523-35-9)

Flindokalner, an anxiolytic agent, is a positive modulator at neuronal Kv7 channels and calcium-activated K+ channels (BKCa) in HEK293 cells. Flindokalner can b...

CAS 55985-32-5 Nicardipine

Nicardipine
(CAS: 55985-32-5)

Nicardipine is a calcium channel blocker used to treat high blood pressure and angina.

CAS 77-41-8 METHSUXIMIDE

METHSUXIMIDE
(CAS: 77-41-8)

Mesuximide is a succinimide anticonvulsant medication. The therapeutic efficacy of methosuximide is due to its pharmacologically active metabolite, N-desmethylm...

CAS 63-91-2 L-phenylalanine

L-phenylalanine
(CAS: 63-91-2)

L-Phenylalanine, a α-amino acid, is an antagonist at α2δ calcium channels (Ki =980 nM).

CAS 79700-61-1 Dopropidil

Dopropidil
(CAS: 79700-61-1)

Dopropidil, also called as ORG 30701, is a cardioactive drug to be classified as a calcium antagonist with combined class I and class VI antiarrhythmic properti...

CAS 1380341-99-0 GAL-021

GAL-021
(CAS: 1380341-99-0)

GAL-021 a novel intravenous BKCa-channel blocker potentially for the treatment of respiratory depression.

CAS 30484-77-6 Flunarizine Dihydrochloride

Flunarizine Dihydrochloride
(CAS: 30484-77-6)

Flunarizine 2HCl is a dihydrochloride salt form which is a calcium channel blocker with a Ki of 68 nM.

CAS 54527-84-3 Nicardipine Hydrochloride

Nicardipine Hydrochloride
(CAS: 54527-84-3)

Nicardipine is a dihydropyridine calcium-channel blocking agent used for the treatment of vascular disorders.

CAS 136941-70-3 Calcium channel-modulator-1

Calcium channel-modulator-1
(CAS: 136941-70-3)

A calcium channel modulator that blocks aortic contraction (IC50= 0.8 μM)

CAS 132203-70-4 Cilnidipine

Cilnidipine
(CAS: 132203-70-4)

Cilnidipine is a unique L-type and N-type calcium channel blocker, used for high blood pressure treatment.

CAS 180090-15-7 CP-​060

CP-​060
(CAS: 180090-15-7)

CP-​060 is a novel type of Ca(2+) antagonist possessing both Ca(2+) overload inhibition, with antioxidant and cardioprotective activities.

CAS 75530-68-6 Nilvadipine

Nilvadipine
(CAS: 75530-68-6)

Nilvadipine is a potent calcium channel blocker with an IC50 of 0.03 nM.

CAS 1072018-68-8 TTA-P2

TTA-P2
(CAS: 1072018-68-8)

TTA-P2 is a selective T-type calcium channel blocker. It blocks T-type currents with an IC50 of 100 nM and stabilized channel in the inactive state in rats DRGs...

CAS 128229-52-7 TAMOLARIZINE

TAMOLARIZINE
(CAS: 128229-52-7)

Tamolarizin is a calcium antagonist originated by Nippon Chemiphar. Tamolarizin can induce the increase of GABA in the cerebellum and medulla oblongata followin...

CAS 111011-53-1 EFONIDIPINE HCL

EFONIDIPINE HCL
(CAS: 111011-53-1)

The hydrochloride salt form of Efonidipine which could be effective in the treatment of cardiovascular disease as a blocker of T-type and L-type calcium channel...

CAS 152-11-4 Verapamil HCl

Verapamil HCl
(CAS: 152-11-4)

Verapamil HCl is an L-type calcium channel blocker that is a class IV anti-arrhythmia agent.

CAS 111011-76-8 Efonidipine hydrochloride monoethanolate

Efonidipine hydrochloride monoethanolate
(CAS: 111011-76-8)

The hydrochloride monoethanolate salt form of Efonidipine which has been launched for hypertension and discontinued for cerebrovascular disorders.

CAS 60142-96-3 Gabapentin

Gabapentin
(CAS: 60142-96-3)

Gabapentin is structurally similar to GABA and is reported in various research studies to increase GABA concentrations within the brain. Gabapentin is also note...

CAS 144604-00-2 Diltiazem Malate

Diltiazem Malate
(CAS: 144604-00-2)

Diltiazem is a calcium channel antagonist. It can relax the smooth muscles in the walls of arteries, allow blood to flow more easily, and lower blood pressure. ...

CAS 116666-63-8 Mibefradil dihydrochloride hydrate

Mibefradil dihydrochloride hydrate
(CAS: 116666-63-8)

The dihydrochloride hydrate salt form of Mibefradil which is a calcium channel blocker with modest selectivity for T-type Ca2+ channels so that it could be used...

Chemical Structure

CAS 100427-26-7 Lercanidipine

Quick Inquiry

Verification code

Featured Items